A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants
Clinical trial NCT02993926 · COMPLETED
Trial details
- NCT number
- NCT02993926
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-06-24
- Primary completion
- 2018-09-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.